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Clinical  mastitis  results  in  considerable  economic  losses  for  dairy  producers  and  is most commonly  diag-
nosed  in early  lactation.  The  objective  of  this  research  was  to estimate  the economic  impact  of  clinical
mastitis  occurring  during  the ﬁrst 30  days  of  lactation  for  a representative  US dairy.  A  deterministic  par-
tial budget  model  was  created  to  estimate  direct  and  indirect  costs  per  case  of clinical  mastitis  occurring
during  the  ﬁrst  30 days  of  lactation.  Model  inputs  were  selected  from  the  available  literature,  or  when
none were  available,  from  herd  data.  The  average  case  of  clinical  mastitis  resulted  in  a total  economic
cost of $444,  including  $128  in direct costs  and $316  in  indirect  costs.  Direct  costs  included  diagnostics
($10),  therapeutics  ($36),  non-saleable  milk  ($25),  veterinary  service  ($4),  labor  ($21),  and  death  loss
($32).  Indirect  costs  included  future  milk  production  loss  ($125),  premature  culling  and  replacement  loss
($182), and future  reproductive  loss  ($9).  Accurate  decision  making  regarding  mastitis  control  relies  on
understanding  the  economic  impacts  of  clinical  mastitis,  especially  the  longer  term  indirect  costs  that
represent  71%  of  the  total  cost  per  case  of  mastitis.  Future  milk  production  loss  represents  28% of  total
cost,  and future  culling  and  replacement  loss  represents  41%  of  the  total  cost  of a case  of  clinical  mastitis.
In  contrast  to older  estimates,  these  values  represent  the current  dairy  economic  climate,  including  milk
price ($0.461/kg),  feed  price  ($0.279/kg  DM  (dry  matter)),  and  replacement  costs  ($2,094/head),  along
with the  latest  published  estimates  on  the  production  and  culling  effects  of clinical  mastitis.  This  eco-
nomic  model  is designed  to be  customized  for speciﬁc  dairy  producers  and  their herd  characteristics  to
better  aid  them  in developing  mastitis  control  strategies.
©  2015  The  Authors.  Published  by  Elsevier  B.V.  This  is  an  open  access  article  under the  CC  BY-NC-ND. Introduction
Clinical mastitis has been identiﬁed as the most common cause
f morbidity in adult dairy cows in the United States (NAHMS,
007). Based on surveys conducted in 1996, 2002, and 2007, the
ercentages of cows with clinical mastitis increased over time.
hese surveys also indicated the top reasons cows were perma-
ently removed from a herd were udder or mastitis problems and
eproductive problems. Additionally, mastitis and calving prob-
ems were the top reasons identiﬁed for cow mortality. Clinical
astitis results in many negative outcomes for the cow including
ain, decreased production, culling, and death. The dairy producer
ncurs the cost of these negative outcomes through reduced quality
nd quantity of milk, as well as increased production costs. Intra-
∗ Corresponding author at: Elanco Animal Health, 2500 Innovation Way, Green-
eld, IN 46140, United States. Fax: +1 706 548 5625.
E-mail address: moverton@elanco.com (M.W.  Overton).
ttp://dx.doi.org/10.1016/j.prevetmed.2015.11.006
167-5877/© 2015 The Authors. Published by Elsevier B.V. This is an open access article unlicense (http://creativecommons.org/licenses/by-nc-nd/4.0/).
mammary infections may  be subclinical infections in which the
mammary secretions are not visually abnormal in color or consis-
tency, or they may result in clinical mastitis (CM) in which there
are abnormalities detectable in the milk, udder, or animal (Ruegg,
2011). Although subclinical mastitis is more prevalent than clini-
cal mastitis, the economic impact of subclinical infections is more
difﬁcult to quantify and predict across herds due to the variability
in herd level screening intensity and case deﬁnition. There is sig-
niﬁcantly more published information regarding the impact of CM
on health, productivity and culling risk as compared to subclini-
cal mastitis; thus, this study focuses on CM.  Lactational incidence
of subclinical and clinical mastitis varies greatly between herds,
but the probability of acquiring an infection is consistently higher
during the early dry period (Bradley and Green, 2004). The appar-
ent incidence of mastitis that develops during the dry period is very
low due to the lack of daily observation of the mammary secretions.
However, the highest risk period for the detection of CM is in early
lactation (Ruegg, 2011), and includes the detection of infections
acquired during the dry period, as well as infections that occurred
der the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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n early lactation. Clinical mastitis in the periparturient period can
ave a great impact on lactation performance, affecting both the
ammary gland and the overall health of the cow. The dry period
nd the early fresh period represent the greatest opportunity for
anagement interventions to improve, or potentially worsen, the
ealth of the udder and its ability to produce quality milk through-
ut lactation, as a large proportion of cases are observed or may  be
ttributed to this time period (Natzke, 1981).
Clinical mastitis can result in a wide spectrum of negative conse-
uences, and its severity is commonly scored based on the extent of
issue involvement (Ruegg, 2011; Oliveira and Ruegg, 2014). Mild
M (grade 1) describes an infection limited to clinically abnormal
ilk; moderate CM (grade 2) also includes an abnormal udder in
ts clinical presentation; and severe CM (grade 3) corresponds to
bnormal milk, an abnormal udder, and systemic signs of disease.
ows affected with different severities of CM are likely to suffer
ifferent short and long term health and production consequences,
eceive different treatments (Oliveira and Ruegg, 2014), and there-
ore have different economic impacts. Clinical mastitis has direct
conomic effects including diagnostic costs, treatment costs, the
ost of non-saleable milk, labor and veterinary costs, and death, but
M also has long term health effects that inﬂuence future milk pro-
uction (Wilson et al., 2004; Schukken et al., 2009), future culling
isk (Miliansuazo et al., 1988; Beaudeau et al., 1995; Grohn et al.,
998), and future reproductive efﬁciency (Santos et al., 2004).
The economic impact of CM is typically much larger than that
f many other clinical diseases of dairy cattle, and much work
as been done to estimate losses at the cow level, the herd level,
nd the industry level. Several methods have been used to esti-
ate the economic effects of mastitis, including partial budgeting
Kossaibati and Esslemont, 1997), dynamic optimization program-
ing (Bar et al., 2008), and decision tree analysis (Pinzon-Sanchez
t al., 2011). The differences in these methods, along with different
nputs used in the models, result in wide ranges in the published
stimates of the economic effects of mastitis (Halasa et al., 2007).
ost published work has focused on mastitis that occurs through-
ut lactation, but little has been done to evaluate the speciﬁc impact
f mastitis occurring within the ﬁrst 30 days in milk (DIM). Cows
hat experience early lactation infections have the potential for
reater negative impact due to the preponderance of lactational
ime remaining. Accurate economic analysis of the disease, and
ore speciﬁcally, a good understanding of the corresponding costs
s they relate to early lactation mastitis, is important so the dairy
roducer can make informed decisions pertaining to the prevention
nd management of CM on the farm.
The purpose of this study was to create an accurate and cus-
omizable tool to be used by dairy veterinary consultants to help
heir clients assess the economic effects of CM during the ﬁrst 30
ays of lactation in order to better guide decision making and man-
gement interventions during the transition period.
. Materials and methods
.1. Overview
A deterministic partial budget was created using spreadsheet
oftware (Microsoft Excel, Redmond, WA)  to estimate the economic
mpact of CM that is diagnosed within the ﬁrst 30 DIM. Model inputs
Table 1 and Table 2) were selected from the available literature
ased on their scientiﬁc merit and applicability, or, when none were
vailable, from clinical experience with actual herd data. In some
nstances, there was considerable variation in the published impact
most commonly risk ratios or odds ratios) associated with CM.
n these cases, a blended mean estimate was used to smooth the
mpact of a very low or very high estimate. When actual herd data Medicine 122 (2015) 257–264
were used, the estimates were derived from a convenience sam-
ple of dairy herds assimilated by one of the authors (Overton) from
U.S herds that were consistent in size and management approach
as described in the model. The cows represented by this compila-
tion include over 30,000 animals from average to above average
managed herds that utilized DairyComp305 on-farm management
software, were primarily free stall housed, fed total mixed rations
balanced by a professional nutritionist, and were located in the
upper Northeast, Midwest, Northwest, West or Southwest regions
of the U.S.
The economic impact per case of CM was  divided into direct and
indirect costs. Direct costs include diagnostic testing, therapeutics,
non-saleable milk, veterinary service, labor, and death loss. Indirect
costs include future milk production loss within the remainder of
the current lactation, cost associated with premature culling and
replacement, and reproductive loss during the current lactation
that is attributable to early lactation mastitis.
Model inputs were based on a typical large Holstein dairy herd
using modern production practices in the United States of Amer-
ica with 1000 animals calving per year; 38% of the calvings were
assumed to be primiparous animals. The milk price of $0.461 per
kilogram of milk was  a 3-year average of net pay prices received
by dairy farmers for their milk, including all payments received
for milk sold and all costs associated with marketing the milk (i.e.,
mailbox prices) from January 2012 to December 2014 as reported
by the USDA Agricultural Marketing Service (USDA, 2014).
Within the model, non-saleable milk could either be discarded
or used to feed replacement heifers. This non-saleable milk includes
milk from cows with CM,  cows being treated with therapies that
require milk withdrawal, and milk from cows following therapy
but before milk is cleared for human consumption and sale. It was
assumed that feeding non-saleable milk to calves would allow pro-
ducers to displace purchased milk replacer powder. Since historical
prices for commercial milk replacer are not typically published by
any public information source, the authors obtained the histori-
cal monthly price of a commercial 28% protein and 15% fat milk
replacer from a U.S. national manufacturer and distributor. The 3-
year (January 2012 to December 2014) average price on a ﬂuid basis
was $0.426 per kilogram (92.3% of the value of milk). While the cost
of milk replacer reﬂects the value of non-saleable milk that is used
to displace purchased milk replacer, this value was discounted to
85% of its cost, since not all non-saleable milk is suitable to be fed to
calves, and the supply of non-saleable milk may  be greater than the
need for calves. Based on this substitution approach, non-saleable
milk used to feed calves was assumed to have a value of $0.362
per kg of liquid milk. Thus, the economic loss of a kilogram of non-
saleable milk was equal to $0.461 minus $0.362, or $0.099 of lost
potential value if the milk had been traditionally marketed.
First lactation fresh animals were valued at $2094 per head,
based on a 3-year average of reported prices from January 2012 to
December of 2014 (Livestock Marketing Information Center, 2014).
The value of older animals was  calculated based on a curvilin-
ear depreciation model that accounted for lactation-speciﬁc culling
risk and expected future salvage value and was equal to $1973 per
head. Relative to straight line depreciation, where the market value
of a cow depreciates a constant amount per year from the begin-
ning value to the ending value, the model depreciates cows slower
in the initial years and then faster in the last years (i.e., market
value decreases at an increasing rate from beginning value to end-
ing value). Market price for culled animals was  $1.84 per kg live
weight, which was  a 3-year average of reported prices from January
2012 to December of 2014 (USDA, 2014); the income received for an
animal sold was adjusted for the risk of condemnation (White and
Moore, 2009). Lactational culling risk, including deaths and animals
sold, was  25% for ﬁrst lactation animals (20.5% sold and 4.5% died),
and 46% for mature animals (36% sold and 10% died), as derived
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Table  1
Deterministic model inputs to estimate the cost of clinical mastitis in the ﬁrst 30 days of lactation.
Input Sourcea
Income Milk price $0.461 /kg USDA (2014)
Market cow price $1.845 /kg USDA (2014)
Reproduction 21-day pregnancy rate (50-day VWPb) 22 % Norman et al. (2009); Dairy Metrics (2015)
Non-saleable milk value Feed calves $0.362 /kg Milk replacer manufacturerc
Discarded $0.00 /kg
Nutrition Feed price (lactating cow TMRd) $0.279 /kg DMe feed USDA (2014)
Energy density of feed 1.70 Mcal NELf/kg DM feed
Energy required to produce marginal milkg 0.71 Mcal of NEL/kg milk National Research Council (2001)
Marginal milk value $0.346 /kg Calculated value
a Data entered into the model as inputs may  be adjusted or calculated from referenced sources.
b VWP  = voluntary waiting period.
c Non-saleable milk value was  calculated from the cost of milk replacer provided by an anonymous milk replacer manufacturer and distributor.
d TMR  = total mixed ration.
e DM = dry matter.
f NEL = net energy for lactation.
g Marginal milk = incremental milk resulting from increasing nutrient intake over and above maintenance requirements.
Table 2
Lactation group speciﬁc deterministic model inputs to estimate the cost of clinical mastitis in the ﬁrst 30 days of lactation.
Input Overall Lact = 1 Lact > 1 Sourcea
Calving % of calvings/year by lactation 38% 62% Compiled herd datab
# of animals calving per year 1000 380 620
Culling Average value of cows in lactation $2094 $1973 Livestock Marketing Information Center (2014)
Culling risk over complete lactation 38% 25% 46% Compiled herd data
Average body weight (kg) 662 544 735
Market value if sold $1173 $964 $1301 USDA, 2014
Fresh cows Avg. milk production/cow at 1–30 DIM (kg) 28.3 22.7 31.8 Compiled herd data
Mastitis Mastitis incidence during ﬁrst 30 DIM 6% 6% 6% Wilson et al. (2014)
Mild mastitis (% of all mastitis) 50% Oliveira and Ruegg
(2014)Moderate mastitis (% of all mastitis) 40%
Severe mastitis (% of all mastitis) 10%
% First cases gram positive 35% Schukken et al. (2009)
% First cases gram negative 35%
%  First cases “otherc” 30%
Recurrence risk (% of cases with 2nd case) 33% 26% 38% Hertl et al. (2011); Cha
et al. (2013)Recurrence risk (% of cases with 3rd case) 13% 8% 16%
a Data entered into the model as inputs may  be adjusted or calculated from referenced
b Compiled herd data estimates were derived from a convenience sample of dairy herd
c “Other” includes included no growth, yeast, Trueperella pyogenes, and other organism
Table 3
Culling risksa across lactation by lactation group to estimate the cost of premature
culling and death per case of clinical mastitis.
Lact 1 Lact > 1
DIM category Sold Died Sold Died
1–30  2.6% 3.2% 4.1% 4.0%
31–60 1.7% 1.3% 2.5% 1.3%
61–90 1.6% 0.7% 1.9% 0.9%
91–120 2.4% 0.5% 2.4% 0.7%
121–150 1.2% 0.2% 2.0% 0.8%
151–180 0.9% 0.2% 2.6% 0.5%
181–210 0.9% 0.3% 2.4% 0.5%
211–240 0.8% 0.2% 2.4% 0.4%
241–270 0.8% 0.2% 3.0% 0.1%
271–300 0.8% 0.2% 2.7% 0.3%
301–330 0.9% 0.4% 2.2% 0.2%
>330  5.5% 1.1% 7.9% 0.5%
Overall 20.5% 4.5% 36.0% 10.0%
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viously described and is below the values presented by Normana Risks are presented as cows culled as a percentage of those that calved, and
ounded to one decimal point.
rom the previously described herd data set. These parity speciﬁc
verall lactation culling risks were used to model proportion sold
nd died in 30-day increments across the entire lactation based
pon compiled data from herds across the U.S and are presented
n Table 3. Animals that died on the farm incurred a $50 cost for
isposal. Lactating cows were fed a balanced total mixed ration
TMR) with an energy density of 1.70 Mcal of Net Energy for lac- sources.
s assimilated by one of the authors (Overton) from U.S herds.
s.
tation per kg of dry matter valued at $0.279 per kg of dry matter,
based on reported prices of monthly feed costs from January 2012
to December 2014 (USDA, 2014).
Maintenance feed requirements are essentially constant
whether a cow has CM in the ﬁrst 30 days or not; however, total
feed required will vary if milk production varies due to the energetic
requirements of milk production. The difference between total milk
production over the lactation with and without CM in the ﬁrst 30
days is referred to in this case as marginal milk. Given fat, protein,
and lactose levels in the milk of 3.7%, 3.1%, and 4.85%, respectively,
the Mcal of Net Energy for lactation per kg of marginal milk is 0.71
(National Research Council, 2001). This energetic feed requirement,
along with the previously mentioned feed cost and ﬂuid milk price,
result in the value of a marginal kilogram of milk of $0.346. This
value is then used to estimate the lost value of milk that is not
produced over the remainder of the lactation as a result of CM.
Reproductive performance was described using herd average
21-day pregnancy rate which is deﬁned as the number of cows
eligible for pregnancy that actually became pregnant divided by
the number of eligible 21-day cycles at risk. The annual average
whole herd 21-day pregnancy rate following a 50-day voluntary
waiting period was  input as 22%. This value reﬂects the mean of
the multi-herd U.S. data set used for the culling estimates as pre-et al. (2009), and above the mean value (21%) derived from a data
pull with Dairy Metrics (Dairy Metrics, 2015), using data from 2184
herds containing 200 cows or more in all U.S. states. Average milk
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roduction in the ﬁrst 30 days of lactation was 22.7 kg per cow per
ay for primiparous cows and 31.8 kg per cow per day for multi-
arous cows.
The incidence risk of clinical mastitis in the ﬁrst 30 days of lacta-
ion was input as 6% for both ﬁrst lactation animals and for second
nd greater lactation animals (Wilson et al., 2004). This means that
% of all cows calving experienced one or more cases of clinical
astitis within the ﬁrst 30 DIM. While other estimates describe
ncidence levels within the ﬁrst 30 DIM that were signiﬁcantly
igher (17% and 15% in housed and pasture-based herds, respec-
ively) (Green et al., 2007), we chose to use the 6% estimate from
ilson et al. due to the corresponding milk loss estimates that
ere included and due to the closer ﬁt to the herd performance
epresented by the data set used to estimate culling risks across
ime. To estimate the long term consequences of CM, the distribu-
ion of CM severity and causal organisms was built into the model.
ild CM (grade 1) accounted for 50% of all CM cases, moderate CM
grade 2) accounted for 40%, and severe (grade 3) accounted for
he remaining 10% of cases of CM (Oliveira and Ruegg, 2014). Gram
ositive pathogens accounted for 35% of all cases of clinical masti-
is, gram negative pathogens accounted for 35%, and the remaining
0% were grouped as “other causes”, which included no growth,
east, Trueperella pyogenes, and other organisms (Schukken et al.,
009). Primiparous animals with a ﬁrst case of CM had a 26% risk
f having another case within the same lactation, and an 8% risk
f having a third case (Hertl et al., 2011; Cha et al., 2013). Mul-
iparous animals with a ﬁrst case of CM had a 38% risk of having
nother case within the same lactation, and a 16% risk of having a
hird case (Hertl et al., 2011; Cha et al., 2013). Days to recurrence
as been reported to range from 15 to 86 days with a mean time
o recurrence of approximately 7 to 8 weeks, and recurrence of CM
n this model was input as an interval of 8 weeks between cases
Hertl et al., 2011; Pinzon-Sanchez et al., 2011; Oliveira et al., 2013).
astitis increased the risk of culling (sold for slaughter) through-
ut lactation by a factor of 1.8 (Miliansuazo et al., 1988; Beaudeau
t al., 1995; Grohn et al., 1998), and increased the risk of death by
 factor of 1.2 (Seegers et al., 2003).
.2. Direct costs
The cost of diagnostics per case was determined by the cost
f milk microbiological culture done at a local veterinary clinic;
ll cases of CM incurred the cost of microbiological culture. The
herapeutic cost per case of mastitis was calculated using com-
on  treatment protocols for cases of mild, moderate, and severe
astitis, and are described in Table 4. The medications, route of
dministration, dosage, and number of treatments are not intended
o be treatment recommendations but rather to reﬂect treatment
rotocols commonly used on large, commercial US dairies (Oliveira
nd Ruegg, 2014). Mild mastitis cases received only intramammary
herapy that resulted in a total of six days of non-saleable milk.
oderate cases of CM received intramammary therapy, an intra-
enous anti-inﬂammatory drug, and an oral electrolyte solution;
hese treatments resulted in six days of non-saleable milk. Severe
ases were treated with intramammary antimicrobials, parenteral
ntimicrobials, an anti-inﬂammatory drug, intravenous hypertonic
aline solution, and one treatment with an oral electrolyte solution.
evere cases of CM incurred a total of seven days of non-saleable
ilk. Some of the treatments described represent extra-label drug
se (ELDU) in the US, and should only be performed following the
ules of the US Food and Drug Administration Animal Medicinal
rug Use Clariﬁcation Act within the context of a valid veterinary
lient patient relationship. The cost of milk withdrawal was cal-
ulated based on the difference in the values of non-saleable milk
nd saleable milk which were impacted by the decision made by
he farm to either feed or discard the waste milk. The inclusion of Medicine 122 (2015) 257–264
the option to feed the waste milk in the model is not intended to
be an endorsement of this practice but rather to reﬂect the man-
agement practices in place on many US dairies. According to the
NAHMS (2002) report, 87.2% of operations fed non-saleable milk
to replacement heifers (NAHMS, 2002). Based on common practice
on large conventional dairies in the US and published data (Richert
et al., 2013), the cost of veterinary service was  only incurred for 30%
of the severe cases of mastitis, and included 30 min  of professional
time at $130 per hour and a trip fee of $30. The cost of treatment
labor was  calculated based on the treatments given, the estimated
amount of time required for each, and a cost of labor of $14 per
hour.
The number of deaths that were attributable to CM was cal-
culated using population attributable fraction (AFp) using the
following formula (Dohoo et al., 2003):
AFp = Pe × (RRe − 1)1 + Pe × (RRe − 1)
where Pe is the incidence of the exposure (incidence of mastitis)
and RRe is the relative risk of death due to that exposure. Since the
incidence of mastitis is 6% and the RR of death due to mastitis is
1.2 (Seegers et al., 2003), then the AFp is equal to 1.19%. For the
ﬁrst lactation group, since the overall risk of death was  4.5% of 380
cows that calved, the number of deaths attributed to CM was 0.20
animals. For the multiparous group, since the overall risk of death
was 10% of 620 cows that calved, the number of deaths attributed to
CM was  0.73 animals. Cows that died as a result of mastitis incurred
a cost of disposal as well as the loss of current estimated value (i.e.,
market value of lactating cow). This calculation was performed for
each lactation group, and the number and cost of deaths attributed
to CM were then assigned to all cases of CM to estimate a cost per
case.
2.3. Indirect costs
Milk production loss was calculated using the average of two
estimates in the literature (Wilson et al., 2004; Schukken et al.,
2009). From Schukken’s work, the proportion of gram positive,
gram negative and other bacteria were used to calculate future
losses. The milk loss was calculated by monthly intervals, taking
into account the culling risk for each of the monthly periods, as well
as the recurrence risk of mastitis from the model inputs. As cows
that had mastitis were culled or died, their predicted subsequent
milk production losses were removed from the model. The same
method was used with the weekly milk production losses reported
in the Wilson et al. study, although pathogen prevalence was  not
considered in those estimations. The estimate of milk production
loss was  multiplied by the marginal milk value to estimate the cost
of the milk production loss by parity group.
Using a relative risk of culling (sold for slaughter) of 1.8 for
cows with CM (Miliansuazo et al., 1988; Beaudeau et al., 1995;
Grohn et al., 2005), the total number of cows culled throughout
lactation attributable to CM that occurred in the ﬁrst 30 days of
lactation was calculated for each parity group using the population
attributable fraction equation presented previously. For the ﬁrst
lactation group, using the relative risk above, an incidence of CM
of 6%, and a baseline culling risk of 20.4%, the AFp was equal to
4.58% of culled animals, or 3.55 attributable culled animals. For the
multiparous group, using the same inputs and a baseline culling
risk of 36%, the AFp was equal to 4.58% of culled animals, or 10.23
attributable culled animals. This estimate of attributable culls was
then multiplied by the difference in the current estimated value
(i.e., market value of lactating cow) and the net income received
from culling to calculate the cost of premature culling and replace-
ment for all cases. The cost of culling and replacement for all cases
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Table  4
Model inputs for therapeutic options for CM by severity scorea used to estimate the therapeutic cost per case of clinical mastitis.
Severity score Therapy Minutes of laborb Days of treatment Days of withdrawal following treatment Days of non-saleable milkc
1 IMMd hetacillin K 10 3 3 6
IMM  ceftiofur HCl 10 3 3 6
2  IVe NSAIDf 15 1 1.5
Oral electrolyte solution 15 1 0
IMM  ceftiofur HCl 10 4 3 7
SQg ceftiofur HCl 3 4 0
3  IV NSAID 15 2 1.5
IV  hypertonic saline 10 1 0
Oral electrolyte solution 15 1 0
a Some of the treatments described represent extra-label drug use (ELDU) in the US, and should only be performed following the rules of the US Food and Drug Administration
Animal Medicinal Drug Use Clariﬁcation Act within the context of a valid veterinary client patient relationship.
b Labor is presented as minutes of farm labor required to perform the described treatment for each administration.
c Days non-saleable milk reported for therapy with highest sum of treatment and withdrawal.
d IMM  = intramammary infusion.
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f NSAID = non-steroidal anti-inﬂammatory drug.
g SQ = subcutaneous injection.
as then averaged over the number of cows with CM to determine
he cost of culling and replacement per case of CM.
The economic impact of CM in the ﬁrst 30 days of lactation
n reproductive performance was modeled using the assumption
hat a case of mastitis would lead to a four day delay in time to
rst service and a 25% reduction in ﬁrst service conception risk
Santos et al., 2004). These data, as well as the baseline inputs from
he model were entered into a spreadsheet based model (Overton,
009) to estimate the expected impact on 21-day pregnancy rate
nd proﬁtability. The reproductive model considers annualized
eplacement costs, the marginal feed consumed by cows produc-
ng marginal milk, the change in marginal milk produced based
pon a change in expected DIM, feed consumed by additional
on-lactating cows, additional costs for housing, labor or medical
xpenses, and extra costs associated with the change in repro-
uctive management and efﬁciency. Due to the higher culling risk
ssociated with the occurrence of CM in the ﬁrst 30 days of lac-
ation, only 39% of affected cows survived the lactation (not sold
r died). Those surviving animals incurred the cost associated with
 change in reproductive performance, but the total cost for the
urvivors was averaged over all cases such that all cases diagnosed
ith a case of mastitis in the ﬁrst 30 days of lactation incurred a
eproductive loss cost. Direct and indirect costs were calculated on
n incident case basis for both ﬁrst lactation and older animals, and
hen the direct costs, excluding death loss, were adjusted for the
ost of recurrence of clinical mastitis for the duration of that lac-
ation. The overall average cost of a case of clinical mastitis for all
ows is based on the cost per case for each lactation category, and
t is adjusted for the herd parity distribution and the mastitis risk
or each lactation category.
In order to show how sensitive the cost of mastitis is to vary-
ng economic assumptions, the effect of changing key price and
ost variables was performed within the observed ranges of prices
mean +/−  one or two standard deviations) within the time period
sed (January 2012 to December 2014).
. Results and discussion
Based on the model inputs, the overall cost per case of clin-
cal mastitis during the ﬁrst 30 days in lactation is presented in
able 5. Direct costs account for only 29% of the total costs of a case
hen non-saleable milk is used to feed calves, whereas indirect
osts account for the remaining 71%. Therapeutic costs, which are
ften the most visible cost to producers, represent only 8% of the
otal costs of a case of clinical mastitis in this scenario.The cost of non-saleable milk is dependent on how the farm uti-
lizes this potential feed. Discarding non-saleable milk results in a
total loss of its value. The practice of feeding non-saleable milk to
replacement heifers is common in the United States (NAHMS, 2002)
and has been shown to be an effective and economical method of
raising heifers (Godden et al., 2005). Based on this model in which
non-saleable milk is fed to calves, the cost of non-saleable milk due
to a case of CM is $25, which represents 5.7% of the total cost per
case. If the non-saleable milk is discarded, the cost increases by $92
bringing the total cost per case to $536, and increases the cost of
non-saleable milk to 22% of the total cost per case. Based on this,
the decision to feed or discard non-saleable milk must be carefully
evaluated, taking into account not only its value, but also its avail-
ability, nutritional quality, bacterial quality, day-to-day variation
in solids level, and the potential for contributing to antimicrobial
resistance.
The cost of veterinary service of $4 represents a small amount of
the cost (1% of total costs per case) in this example, but this impact
may  be greater on farms that rely more heavily on veterinarians,
where veterinary service is more costly, or on farms with a higher
incidence of severe mastitis. Our calculations are in contrast to the
economic assessment by Heikkila et al. (2012), in which veterinary
service and drugs represented from 24% to 31% of the cost of CM.
This difference may  be attributed to differences in veterinary labor
and drug costs between the United States and Finland, or in the
estimations of the other component costs of CM.  In our model, if
the veterinarian’s presence is required on the farm to conﬁrm the
diagnosis and perform treatments on the ﬁrst day with the pro-
ducer performing the follow up treatment, the cost of veterinary
service increases to $106, which represents 19% of the total cost,
and brings the total cost per case to $551. If in this same scenario,
non-saleable milk is discarded instead of fed to calves, the total cost
per case rises to $644.
The economic impact of death represents only 7% of the total
cost per case. Even though each death represents a large economic
loss, the low incidence of severe mastitis in this model and the rel-
ative risk of death help to dilute that loss across all cases of CM.  The
cost per case is greater for multiparous animals ($40) compared
to primiparous animals ($19), because of the higher baseline inci-
dence of death in these animals and an equivalent relative risk of
death due to CM.
Future milk production loss is a substantial fraction of the eco-
nomic impact of CM (28% of total cost per case, or $125). Previous
studies that estimate milk production loss as a consequence of CM
have a wide range of estimates, especially as they estimate pro-
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Table  5
Breakdown of estimated cost per case of clinical mastitis in the ﬁrst 30 days of lactation.a
Lact = 1 Lact > 1 Overall
Cost per incident case Cost per incident case Cost per incident case % of total cost
Direct
costs
Diagnostics $9 $11 $10 2.3
Therapeutics $30 $40 $36 8.1
Non-saleable milk $18 $30 $25 5.7
Veterinary service $4 $4 $4 0.9
Labor  $19 $22 $21 4.7
Death  loss $19 $40 $32 7.2
Direct  cost/case $100 $146 $128 28.9
Indirect
costs
Future  milk production loss $149 $111 $125 28.2
Premature culling loss $176 $185 $182 40.9
Future  repro. loss $9 $9 $9 2.0
Indirect cost per case $333 $305 $316 71.1
Average  cost per case $444
a Results are rounded to the nearest whole US dollar.
Table 6
Sensitivity analysis of cost per incident case of CM for key economic variables.a
Baseline cost per case of clinical mastitisb $444
Mean Std dev Impact of + 1 std dev change
Milk price, $/kg $0.461 $0.061 +$39.22
Non-saleable milk, $/kg $0.362 $0.025 −$6.40
Feed  price, $/kg $0.279 $0.032 −$4.85
Value  of lactation 1 cows $2094 $426 +$95.65
Market cow price, $/kg $1.845 $0.301 −$45.52
a Other major model inputs include parity breakdown (38% primiparous, 62% multiparous), 21-day pregnancy rate (22%), culling risk (25% for primiparous, 46% for
multiparous), body weight (544 kg for primiparous, 735 kg for multiparous), average milk production in the ﬁrst 30 DIM (22.7 kg for primiparous, 31.8 kg for multiparous),
clinical mastitis incidence in the ﬁrst 30 DIM (6% for primiparous, 6% for multiparous), clinical mastitis severity breakdown (50% mild, 40% moderate, 10% severe), recurrence
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b Based on non-saleable milk being fed to calves. If milk is discarded cost is $536
uction loss several months after the clinical episode. This range
n estimates can be partly attributed to the control group to which
astitic cows are compared. In the Wilson et al. (2004) estima-
ion, cows diagnosed with mastitis were higher producing cows
efore the clinical episode, and the authors compared produc-
ion after clinical mastitis to a predicted lactation curve for those
igher producing cows, not an average lactation curve for cows not
ffected by CM.  Taking this into account approximately doubles
heir estimate of milk loss. In the Schukken et al. (2009), the milk
roduction effects of clinical mastitis were stratiﬁed by pathogen
roups, which allows for more accurate modeling to match herd
athogen prevalence. In this study, we used a blended estimation
f milk loss based on the two cited studies. Another item to consider
s the timing of the clinical mastitis episode. Most studies consider
ny case of mastitis during lactation for inclusion. Wilson’s study
stimated a median onset of clinical mastitis of 22 DIM for ﬁrst lac-
ation animals and of 81 DIM for second-plus lactation animals. Our
tudy focused on clinical mastitis in the ﬁrst 30 DIM, a time when
astitis may  have a greater impact on the future milk production
ver the rest of the lactation (Hagnestam-Nielsen and Ostergaard,
009). Better estimations of long term milk production loss for CM
hat occurs during the ﬁrst 30 DIM would strengthen the milk loss
stimates in our model.
Because milk production is the main driver for an individual
ow’s proﬁtability, and mastitis can have such a large impact on
roduction, mastitis is one of the leading reasons for culling by
airy producers (NAHMS, 2002, 2007). Culling due to mastitis can
ccur at various times within the lactation based upon the other
ssociated reasons for removal. For example, a cow that is in early
actation and signiﬁcantly fails to regain her expected level of milk
roduction is more likely to be culled earlier and closer to the early
actation mastitis event. Other cows that regain varying portions of
heir projected level of milk production may  be culled in mid  to lateus), recurrence risk for a third case of CM during the lactation (8% for primiparous,
se.
lactation after a subsequent case of mastitis or other disease issue.
In this situation, the reduction in milk production due to the early
mastitis contributes to, but may  not intrinsically necessitate the
culling of the cow. Other cows may be culled later due to a failure
to become pregnant that was  at least partially attributed to early
lactation reproductive challenges associated with mastitis. Using
the relative risk of culling due to CM and the attributable fraction
allows us to estimate the cost of incremental culling and replace-
ment that is due to exposure to a CM event. This model reveals that
the cost of premature culling and replacement represents the great-
est cost of all categories examined (41% of total costs, or $182). This
ﬁnding agrees with the report by Down et al. (2013) which found
that “the most inﬂuential ﬁnancial input was the cost of a cull”.
The cost of reduced reproductive efﬁciency ($9) due to CM repre-
sents a small cost relative to other indirect costs. Mastitis may  have
several potential effects on reproductive efﬁciency, including direct
effects of mastitis-associated inﬂammation, as well as effects on
feed intake and energy balance. Effects of systemic inﬂammation,
including that related to CM,  have been implicated in the abnormal
function of the corpus luteum (Santos et al., 2004), but this may
not have clinically observable effects when CM occurs very early
in lactation, when the likelihood of cows having a corpus luteum
is low. Clinical mastitis in the ﬁrst 30 DIM is more likely to exert
its negative impact on reproduction via a negative impact on feed
intake and energy balance, which has a direct effect on the inter-
val to ﬁrst ovulation (Walsh et al., 2007). However, the distribution
of CM severity, the delay between a case of CM that occurs before
30 DIM and the ﬁrst breeding, as well as hormonal interventions
to stimulate cyclicity may  negate some of those effects on cyclic-
ity and risk of conception, resulting in a relatively small effect as
described by Santos et al. (2004).
The incidence of CM in the ﬁrst 30 DIM and the cost per case of
CM can vary greatly between herds or management systems. This
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Table  7
Sensitivity analysis. Cost per incident case of CM by replacement cost and milk price.a
Replacement heifer cost, $/head Milk price, $/kg
$0.34 $0.40 $0.46 $0.52 $0.58
Feed non-saleable
milkb
$1668 $276 $309 $348 $388 $427
$2094 $371 $405 $444 $483 $522
$2520 $467 $500 $540 $579 $618
Discard non-saleable
milkc
$1668 $362 $402 $441 $480 $519
$2094 $458 $497 $536 $576 $615
$2520 $554 $593 $632 $671 $711
a Other major model inputs include parity breakdown (38% primiparous, 62% multiparous), market cow price ($1.845/kg), 21-day pregnancy rate (22%), marginal milk
value  ($0.342/kg), culling risk (25% for primiparous, 46% for multiparous), body weight (544 kg for primiparous, 735 kg for multiparous), average milk production in the ﬁrst
30  DIM (22.7 kg for primiparous, 31.8 kg for multiparous), clinical mastitis incidence in the ﬁrst 30 DIM (6% for primiparous, 6% for multiparous), clinical mastitis severity
breakdown (50% mild, 40% moderate, 10% severe), recurrence risk for a second case of CM during the lactation (26% for primiparous, 38% for multiparous), recurrence risk
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tor  a third case of CM during the lactation (8% for primiparous, 16% for multiparous
b Non-saleable milk fed to calves has a value of 85% of milk replacer price ($0.426
c Discarded non-saleable milk has a value of $0.000/kg.
nalysis was based on an incidence of CM,  culling risk, and manage-
ent protocols representative of a typical large dairy herd in the
.S. and used a published RR describing the relationship between
astitis and culling. More importantly, the analysis was  based
n the interrelationships of these factors to estimate attributable
ases. If the herd incidence of CM is changed, but culling risk is not,
ll costs per case remain the same other than small changes in death
oss and culling and replacement loss. For example, if we hold all
ther inputs the same, but increase CM incidence from 6% to 12%,
hen the cost per case decreases from $444 to $438. On the other
and, if CM incidence is changed and culling risk is simultaneously
hanged such that RR and proportion of attributable cases remain
onstant, the cost per case for all the direct and indirect costs of
astitis remains the same. When economic models are used to
valuate the effect of management changes, one must be cognizant
f the relationships between inputs. The economic tool based on
his model considers this relationship and modiﬁes the herd culling
isk as the CM incidence changes so that the cost per case for all the
irect and indirect costs are not a function of incidence of CM.
In order to show the effects of variation in some of the most
nﬂuential and volatile model inputs, sensitivity analyses are pre-
ented in Tables 6 and 7. Table 6 shows the impact of a one standard
eviation change of key economic variables on the cost per incident
ase of CM.  Table 7 shows the cost per case of CM for all lactation
roups at various milk prices (mean +/−  two standard deviations)
nd replacement heifer costs (mean +/−  one standard deviation) for
 herd that uses non-saleable milk for calf feed, as well as for a herd
hat discards non-saleable milk. The remainder of the inputs for
his analysis are as described in Tables 1 and 2. From Table 6 it can
e seen that the price of replacement cows has the largest impact
n the cost of a case of CM where one standard deviation increase
$426) increases costs $95.65 per case. The second largest impact
s the price of cull cows, where a one standard deviation increase
n price ($0.30/kg) decreases the cost per case of CM by $45.52. An
ncrease in the price of milk of one standard deviation ($0.06/kg)
ncreases the cost per case of CM by $39.22. Table 7 shows the
osts per case of CM over a range of milk and replacement cow
rices when waste milk is either fed or discarded. Discarding non-
aleable milk results in an increase of $92 across the milk prices
nd replacement heifer costs examined.
One facet of the epidemiology of CM in dairy herds that is not
onsidered in this model is the risk of transmission of contagious
athogens to herdmates (Down et al., 2013). While this can be a
oncern, the authors feel that transmission of pathogens is highly
ependent on the individual herd’s mastitis control strategies. In
his model, it is assumed that the common practice of segregating
r culling animals with contagious mastitis organisms is performed
o reduce the risk of transmission. It has also been reported that inlarge herds in the United States, the proportion of CM caused by
contagious organisms is much lower than that in smaller herds or
in decades past (Oliveira et al., 2013).
This model represents an average case of CM in a hypothetical
herd and uses deterministic model inputs. As more data become
available to provide a better understanding of the true distribution
of key inputs, a stochastic approach to this model may  provide more
information on the variation surrounding each of the components
and the total cost of CM in the ﬁrst 30 days of lactation. However, for
the major drivers of the cost of CM,  currently there are insufﬁcient
data available to completely and accurately estimate the precise
variation of effects of a case of CM.
4. Conclusions
This study examined the cost of clinical mastitis during the ﬁrst
30 days in milk by using recent estimates of its effects, and reﬂects
current market conditions and management practices in the United
States. The ﬁndings show that a majority of the costs associated
with clinical mastitis in the ﬁrst part of lactation are indirect costs
that occur over the remainder of that lactation. There is a large
opportunity to mitigate these costs by managing udder health dur-
ing the transition period to prevent clinical mastitis. Based on the
results of this work, and using the assumption that non-saleable
milk was fed to calves and using minimal veterinary involvement
in treatment, the cost of each incident case of clinical mastitis that
occurs during the ﬁrst 30 days of lactation was  estimated to be $444.
The majority of this cost (71%) is comprised of indirect costs that are
more difﬁcult for producers to “see” because they do not require a
direct cash outlay (e.g., future milk production, premature culling
and replacement, and reproductive losses). However, these indirect
costs reﬂect lost opportunity and impact the economic viability of
the dairy and thus it is important for producers to recognize these
costs.
This method of cost estimation is highly adaptable to individual
farms and allows for evaluation of speciﬁc management inter-
ventions. The concepts described and discussed in this modelling
project help to improve our understanding of the full economic
impact of early lactation mastitis. The model inputs can be cus-
tomized to speciﬁc situations and updated to current economic
conditions. The model structure also allows for future adjustment
of the effects of mastitis as more data become available. However,
since most of the references cited and all of the herd data and major
inputs used were from built from a US production perspective, cau-
tion must be exercised when using this or any model in situations
where actual data inputs vary considerably from those used in the
assumptions for model construction.
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